According to a
new report published by Data Bridge Market Research “Global
Transplant Diagnostics Market”, accounted to USD 2.13 billion in 2016
growing at a CAGR of 9.5% during the forecast period of 2017 to 2024.
Global
Transplant Diagnostics Market Technology (Molecular Assay Technologies
(PCR-Based Molecular Assay Technologies (Real-Time PCR, SSP-PCR, SSO-PCR),
Sequencing-Based Molecular Assay Technologies (Sanger, NGS)), Non-Molecular
Assay Technologies), Product type (Reagents & Consumables, Instruments,
Software & Services), Application (Diagnostic, Research), End User
(Hospitals & Transplant Centers, Commercial Service Providers, Research
Laboratories and Academic Institutes), Geography (North America, Europe, Asia-Pacific,
Europe, South America, Middle East and Africa) and Forecast to 2024.
Request for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-transplant-diagnostics-market
Transplant diagnostics are the
diagnostics tests performed while relocating organ in order to treat organ
failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely
performed by skilled and trained professionals in hospitals & transplant
centers, commercial service providers, research laboratories and academic
institutes.
Report
Drivers and Restraints:
·
Rising Incidence of Chronic and
Infectious Diseases
·
Rising Number of Transplantation Procedures
·
Growing Public-Private
Investments and Funding
·
High costs in performing HLA
matching using PCR and NGS devices
·
Limited Medical Reimbursements
for Transplantation Procedures
Scope
of the Report:
By Technology the market for transplant
diagnostics market is segmented into Molecular Assay Technologies,
Sequencing-Based Molecular Assay Technologies, and Non-Molecular Assay Technologies.
The Molecular Assay Technologies segment is further sub-segmented into
PCR-Based Molecular Assay Technologies, Sequencing-Based Molecular Assay
Technologies, and Non-Molecular Assay Technologies. The PCR-Based Molecular
Assay Technologies are further sub-segmented into Real-Time PCR,
Sequence-Specific Primer-PCR (SSP-PCR), Sequence-Specific Oligonucleotide-PCR
(SSO-PCR), and Other PCR Technologies. The Sequencing-Based Molecular Assay
Technologies are further sub-segmented into Sanger Sequencing, Next-Generation
Sequencing (NGS), and Other Sequencing Technologies.
By product type the transplant
diagnostics market is segmented into reagents & consumables, instruments,
software & services. On the basis of application the market is segmented
into diagnostic, and research.
On the basis of end-users the
transplant diagnostics market is segmented into hospitals & transplant
centers, commercial service providers, research laboratories and academic
institutes.
Speak
to Analyst @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-transplant-diagnostics-market
On the basis of geography,
transplant diagnostics market report covers data points for 28 countries across
multiple geographies such as North America & South America, Europe,
Asia-Pacific, and Middle East & Africa. Some of the major countries covered
in this report are U.S., Canada, Germany, France, U.K., Netherlands,
Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia,
Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North
America is expected to dominate the market.
Competitive
Analysis:
The transplant
diagnostics market is highly fragmented and is based on new product
launches and clinical results of products. Hence the major players have used
various strategies such as new product launches, clinical trials, market
initiatives, high expense on research and development, agreements, joint
ventures, partnerships, acquisitions, and others to increase their footprints
in this market. The report includes market shares of transplant diagnostics
market for global, Europe, North America, Asia Pacific and South America.
Top
Key Competitors:
·
Thermo Fisher Scientific Inc.
·
Bio-Rad Laboratories, Inc.
·
F. Hoffman-La Roche Limited
·
Qiagen N.V.
·
Biomérieux SA
·
Immucor, Inc.
·
Illumina, Inc.
·
Becton Dickinson and Company
·
Caredx, Inc.
·
Gendx
·
Sigma-Aldrich Corporation
·
Abbott
·
DiaSorin S.P.A.
·
Affymetrix, Inc.
·
Omixon Ltd.
·
Olerup SSp AB
·
Linkage Biosciences
Read more about the Global Transplant
Diagnostics Market Visit @ http://databridgemarketresearch.com/reports/global-transplant-diagnostics-market/
Related Report
Global
Cardiac Surgery Instruments Market – Industry Trends and Forecast to 2024
Global Cardiac Surgery
Instruments Market By Product (Clamps, Forceps, Scalpel, Scissors, Needle
Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery,
Pediatric Surgery, Heart Transplant), End User (Hospital, ASC), Geography
(North America, Europe, Asia-Pacific, South America, Middle East and Africa) –
Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-cardiac-surgery-instruments-market/
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research